Analyst Ratings for Perspective Therapeutics Inc (CATX)
CATX Rating Summary
CATX Price Target Summary
- Highest: $18.00 (RBC Capital)
- Lowest: $7.00 (UBS)
- Average: $12.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.88 (+159.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$12.88 (+159.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/19/2026 | Piper Sandler | Biren Amin | New Coverage | Overweight (N/A) |
16.00 (N/A) |
5.03 (4.97) |
-1.19% | Details |
| 11/24/2025 | Truist Securities | Greg Renza | New Coverage | Buy (N/A) |
12.00 (N/A) |
2.09 (4.97) |
137.8% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
